General practice pharmacist-led antipsychotic physical health monitoring: A prospective intervention scoping study

Johnson, C. F., Ingram, F., Thomson, F., Srireddy, P., Jani, B. D. and Greenlaw, N. (2024) General practice pharmacist-led antipsychotic physical health monitoring: A prospective intervention scoping study. Family Practice, (doi: 10.1093/fampra/cmad120) (PMID:38180874) (Early Online Publication)

Full text not currently available from Enlighten.

Abstract

Background People with severe mental health illness die prematurely, often due to preventable cardiometabolic disease, which can be exacerbated by antipsychotic medicines that are effective for treating mental illness. Literature demonstrates that physical health monitoring, as recommended in guidelines, for people receiving antipsychotics is substandard. Therefore, we aimed to scope the potential of a general practice clinical pharmacist (GPCP)-led multidisciplinary intervention optimising adherence to cardiometabolic monitoring guidelines and delivering polypharmacy reviews. Method Prospective intervention scoping study in three urban general practices; one usual care, two intervention. Patients 18–65 years old prescribed oral antipsychotics were identified from records, and invited for cardiometabolic monitoring and GPCP medication review, from January to December 2022. Interventions and onward referrals were recorded and collated. Anonymised pre- and post-review data were analysed, and actions were graded for clinical importance. Results In total 1.5% (210/14,159) of patients aged 18–65 years met inclusion criteria; usual care practice (n = 58); and intervention practices (n = 152). From baseline, the usual care practice achieved an absolute 7% increase in the cardiometabolic monitoring care bundle (glucose/glycosylated haemoglobin, lipids, blood pressure plus body mass index) versus 19–58% in the intervention practices. Two-thirds (92/152) of patients participated in medication reviews, requiring pharmacological and/or non-pharmacological clinical actions. The majority of actions were graded as moderate importance. Seven percentage of patients were identified as new pre-diabetic/diabetic and 6% were at high risk of cardiovascular disease requiring statin initiation. Conclusion A pharmacist-led multidisciplinary general practice-based approach may be effective at optimising cardiometabolic monitoring; identifying and treating diabetic and cardiovascular risk factors.

Item Type:Articles
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Greenlaw, Miss Nicola and Jani, Dr Bhautesh and Srireddy, Dr Pavan
Authors: Johnson, C. F., Ingram, F., Thomson, F., Srireddy, P., Jani, B. D., and Greenlaw, N.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre
Journal Name:Family Practice
Publisher:Oxford University Press
ISSN:0263-2136
ISSN (Online):1460-2229
Published Online:05 January 2024

University Staff: Request a correction | Enlighten Editors: Update this record